Sickle Cell Anemia Skeletal Imaging

No Results

No Results

processing….

Sickle cell disease (SCD) is a chronic hemoglobinopathy of clinical relevance because of its significant morbidity and mortality, particularly in people of African and Mediterranean ancestry. SCD results from a mutated form of hemoglobin, hemoglobin S (HBS), and vascular obstruction and ischemia result in a wide range of clinical problems. ^{[1, 2, 3, 4, 5]}   Effects on the musculoskeletal system include extramedullary hematopoiesis, osteonecrosis, dactylitis (hand-foot syndrome), myonecrosis, and osteomyelitis,with bone disease being one of the most common presentations in patients with SCD. ^{[6, 7, 8, 9, 10]}

MRI is the best method for detecting early signs of changes in bone marrow due to acute and chronic bone marrow infarction, marrow hyperplasia, osteomyelitis, and osteonecrosis. ^{[5, 11, 12, 13, 14]}

Nuclear imaging can also be used to detect early osteonecrosis (see the image below). This modality also plays a role in detecting osteomyelitis. Likewise, indium leukocyte scanning has an important role in diagnosing osteomyelitis.

Plain radiography of the extremities is useful in evaluating subacute and chronic infarction and in assessing the number and severity of prior episodes of infarction (see the images below). Plain radiographs are also excellent for evaluating deformities and other complications of bone infarction.

Osteonecrosis is visible on plain images only in the later stages after the affected bone is substantially damaged.

Ever since carriers of the mutated gene survived the deadly malaria epidemics that were thought to occur thousands of years ago, the gene has continued to survive in malaria-endemic areas. However, in areas such as the United States, where malaria is not a problem, the trait no longer provides a survival advantage and instead poses the threat of sickle cell disease if the carrier’s children inherit the sickle cell gene from both parents (ie, HbSS). Although carriers of sickle cell trait do not suffer from the disease, individuals with one copy of HbS and one copy of a different beta-globin gene variant such as HbC or Hb beta-thalassemia have a less severe form of the disease.

Although the disease is most frequently found in sub-Saharan Africa, it is also found in some parts of Sicily, Greece, southern Turkey, and India, all of which have areas in which malaria is endemic.

The skeletal manifestations of sickle cell disease are the result of changes in bone and bone marrow caused by the chronic tissue hypoxia that is exacerbated by episodic occlusion of the microcirculation by the abnormal sickle cells. The main processes that lead to bone and joint destruction in sickle cell disease are infarction of bone and bone marrow, compensatory bone marrow hyperplasia, secondary osteomyelitis, and secondary growth defects. ^{[13, 6, 7, 8, 9, 10]}

When the rigid erythrocytes jam in the arterial and venous sinusoids of skeletal tissue, the resultant effect is intravascular thrombosis, which leads to infarction of bone and bone marrow. Repeated episodes of these crises eventually lead to irreversible bone infarcts and osteonecrosis, especially in weight-bearing areas. These areas of osteonecrosis (avascular necrosis/aseptic necrosis) become radiographically visible as sclerosis of bone with secondary reparative reaction and eventually result in degenerative bone and joint destruction.

Infarction of bone and bone marrow in patients with sickle cell disease can lead to the following changes: osteolysis (in acute infarction), osteonecrosis (avascular necrosis/aseptic necrosis), articular disintegration, myelosclerosis, periosteal reaction (unusual in the adult), H vertebrae (steplike endplate depression also known as the Reynold sign or codfish vertebrae) (see the first image below), dystrophic medullary calcification, and bone-within-bone appearance.

The shortened survival time of the erythrocytes in sickle cell (10-20 days) leads to a compensatory marrow hyperplasia throughout the skeleton. The bone marrow hyperplasia has the resultant effect of weakening the skeletal tissue by widening the medullary cavities, replacing trabecular bone and thinning cortices.

Deossification due to marrow hyperplasia can bring about the following changes in bone: decreased density of skull, decreased thickness of outer table of skull due to widening of diploe, hair on-end striations of the calvaria (see the images below), and osteoporosis sometimes leading to biconcave vertebrae, coarsening of trabeculae in long and flat bones, and pathologic fractures. ^{[14, 15]}

Patients with sickle cell disease can have a variety of growth defects due to the abnormal maturation of bone. The following growth defects are often seen in sickle cell disease: bone shortening (premature epiphyseal fusion) (see the image below), epiphyseal deformity with cupped metaphysis, peg-in-hole defect of distal femur, and decreased height of vertebrae (short stature and kyphoscoliosis).

Interventional radiologists may play a role in obtaining a sample to identify the infecting organism in osteomyelitis. Also, patients with subperiosteal and soft tissue abscesses may benefit from imaging guided drainage with light sedation, avoiding surgery and general anesthesia.

There are no approved drugs for children with sickle cell disease, but hydroxyurea is approved for the treatment of sickle cell disease in adults. In a meta-analysis of the literature through 2007, Strouse et al studied the efficacy, effectiveness, and toxicity of hydroxyurea in children with sickle cell disease. The investigators found that hemoglobin levels increased from 5-10% to 15-20%; hemoglobin concentration increased modestly (approximately 1 g/L) but significantly; hospitalizations decreased by 56-87%; and the frequency of pain crisis decreased. ^[16]

For patient education information, see the Blood and Lymphatic System Center, as well as Sickle Cell Crisis.

The early plain radiographic findings of dactylitis consist of soft tissue swelling. Periosteal new-bone formation can be seen on radiographs 7-10 days later. Additionally, medullary expansion, cortical thinning, trabecular resorption, and resultant focal lucency may be seen 2-3 weeks after the onset of symptoms, but these findings usually resolve within weeks (see the images below).

Osteonecrosis can affect the articular portions of the long bones. Collapse of the bone surfaces that are affected by osteonecrosis usually result in degenerative joint destruction. Radiographs of the affected joint may show patchy sclerosis initially, followed by flattening of bone (see the images below).

Widened medullary cavities may be noted. In the calvaria, the major trabecular spicules in the widened diploic space are aligned perpendicular to the inner table, giving the skull the characteristic hair-on-end appearance (see the images below).

Thickened bone can be observed. In the extremities, the medullary cavities are widened and the cortices are thinned, with loss of the normal modeling of the bone due to marrow hyperplasia.

Infarction of the central portion of the vertebral endplates results in the characteristic H deformity (angular depression) of vertebral bodies. When present in multiple vertebrae, this finding is virtually pathognomonic for sickle cell disease (see the image below).

Shortening of bone may be depicted. Epiphyseal infarction may produce cone-shaped epiphysis or premature fusion of the epiphysis resulting in abnormal shortening of the involved bone (see the image below).

After multiple infarctions of the long bones, sclerosis may assume the appearance of a bone within a bone, reflecting the old cortex within the new cortex (see the image below).

Regarding myelosclerosis, the cumulative effects from repeated chronic small episodes of infarction result in a mottled, strandlike increased opacity in the medullary region (see the image below).

Although radiography is not as sensitive as other studies for osteomyelitis in the first 1-2 weeks, plain images subsequently show cortical destruction, periosteal new bone, and (with time) sinus tracts and sequestra (see the images below).

Although CT is not an initial study in most patients, CT scans can show findings of osteonecrosis, including sclerosis, collapse of bone (especially femoral heads), and a bone-within-bone appearance. CT may be useful to demonstrate subtle regions of osteonecrosis not apparent on plain radiographs in patients who are unable to have an MRI. ^[17]

Findings of osteomyelitis, including periosteal reaction, cortical or bone destruction, cloacae (sinus tracts), and sequestra or dead bone can be identified on CT scans (see the images below). Bone and soft tissue abscesses are demonstrated on contrast enhanced CT scans as low attenuation fluid collections with peripheral rim enhancement with or without internal gas.

CT is not the test of choice for evaluation of acute osteomyelitis.

MRI allows the early detection of changes in bone marrow due to acute and chronic bone marrow infarction, marrow hyperplasia, osteomyelitis, and osteonecrosis. As with plain radiography, the sine qua non of diagnosing osteomyelitis on MRI is the identification of cortical destruction for which MRI is exquisitely sensitive. ^{[13, 13, 5, 14, 9]}

Acute infarction is characterized by diffuse decreased signal intensity on T1-weighted images and increased signal intensity on T2-weighted images. This change results from bone marrow edema. With time, the process becomes focal, and T1-weighted images show a serpentine line of low signal intensity surrounding hyperintense marrow (see the images below). A double line of low signal intensity surrounding inner high signal intensity is sometimes seen on T2-weighted images.

Bone marrow hyperplasia in patients with sickle cell disease presents as diffuse areas of intermediate signal intensity on T1-weighted images, similar or slightly higher than that of skeletal muscle, and corresponding mildly increased signal on T2-weighted images. This effect is due to the replacement of fatty marrow by hematopoietic marrow.

Chronic bone infarcts, or old infarction and fibrosis, appears as focal areas of decreased signal intensity on both T1- and T2-weighted images. ^[15]  With osteomyelitis, areas of bone infection demonstrate low signal intensity that replaces the usual high signal intensity of fatty marrow on T1-weighted images. This appears as areas of increased signal intensity on T2-weighted images and results from bone marrow edema and/or bone destruction. Bone sequestra, sinus tracts, and subperiosteal abscesses are also clearly identified when present. Fat saturated T1-weighted images with intravenous gadolinium facilitate the identification of bone sequestra, which present as focal low signal intensity defects surrounded by avidly enhancing inflammatory tissue. ^[9]

^[9] Technetium-99m (^99mTc) bone scanning can be used to detect early stages of osteonecrosis, and it is not as costly as MRI. Osteonecrosis can be detected on bone scans, appearing mostly as focal areas of increased activity. Occasionally, areas of decreased uptake can be seen; this is usually seen in early disease. Technetium-99m bone marrow scans demonstrate areas of decreased activity in marrow infarction. ^[18]

Indium-111 (¹¹¹In) white blood cell (WBC) scanning is useful to diagnose osteomyelitis, which appears as an area of increased activity within bone. However, areas of marrow proliferation, which are common in patients with sickle cell, would also demonstrate increased activity on ¹¹¹In WBC scans. The combination of a bone scan and a bone marrow scan has been used to differentiate acute osteomyelitis from bone infarcts in patient with sickle cell, since the clinical presentation of these 2 conditions may be very similar. Areas of bone infarction may be identified by decreased activity on the bone marrow scan with corresponding abnormal uptake on the bone scan. Acute osteomyelitis demonstrates increased activity on the bone scan, with normal activity on the bone marrow scan. ^{[9, 19]}

Olujohungbe A, Howard J. The clinical care of adult patients with sickle cell disease. Br J Hosp Med (Lond). 2008 Nov. 69(11):616-9. [Medline].

Johnson L, Carmona-Bayonas A, Tick L. Management of pain due to sickle cell disease. J Pain Palliat Care Pharmacother. 2008. 22(1):51-4. [Medline].

De D. Acute nursing care and management of patients with sickle cell. Br J Nurs. 2008 Jul 10-23. 17(13):818-23. [Medline].

Archer N, Galacteros F, Brugnara C. 2015 Clinical trials update in sickle cell anemia. Am J Hematol. 2015 Oct. 90 (10):934-50. [Medline].

Sachan AA, Lakhkar BN, Lakhkar BB, Sachan S. Is MRI Necessary for Skeletal Evaluation in Sickle Cell Disease. J Clin Diagn Res. 2015 Jun. 9 (6):TC08-12. [Medline].

Kosaraju V, Harwani A, Partovi S, Bhojwani N, Garg V, Ayyappan S, et al. Imaging of musculoskeletal manifestations in sickle cell disease patients. Br J Radiol. 2017 Mar 10. 20160130. [Medline].

Mauriello A, Giacobbi E, Saggini A, Isgrò A, Facchetti S, Anemona L. Histological features of bone marrow in paediatric patients during the asymptomatic phase of early-stage Black African sickle cell anaemia. Pathology. 2017 Apr. 49 (3):297-303. [Medline].

da Silva Junior GB, Daher Ede F, da Rocha FA. Osteoarticular involvement in sickle cell disease. Rev Bras Hematol Hemoter. 2012. 34 (2):156-64. [Medline].

Ganguly A, Boswell W, Aniq H. Musculoskeletal manifestations of sickle cell anaemia: a pictorial review. Anemia. 2011. 2011:794283. [Medline].

Saito N, Nadgir RN, Flower EN, Sakai O. Clinical and radiologic manifestations of sickle cell disease in the head and neck. Radiographics. 2010 Jul-Aug. 30 (4):1021-34. [Medline].

Dahnert W, ed. Radiology Review Manual. 5th ed. Philadelphia: Lippincott, Williams & Wilkins;. 2003: 158-9.

Putman CE, Ravin CE, eds. Textbook of Diagnostic Imaging. 2nd ed. 1361-439.

Pratesi A, Medici A, Bresci R, Micheli A, Barni S, Pratesi C. Sickle cell-related bone marrow complications: the utility of diffusion-weighted magnetic resonance imaging. J Pediatr Hematol Oncol. 2013 May. 35(4):329-30. [Medline].

Elias EJ, Liao JH, Jara H, Watanabe M, Nadgir RN, Sakai Y, et al. Quantitative MRI analysis of craniofacial bone marrow in patients with sickle cell disease. AJNR Am J Neuroradiol. 2013 Mar. 34 (3):622-7. [Medline].

Watanabe M, Saito N, Nadgir RN, Liao JH, Flower EN, Steinberg MH, et al. Craniofacial bone infarcts in sickle cell disease: clinical and radiological manifestations. J Comput Assist Tomogr. 2013 Jan-Feb. 37(1):91-7. [Medline].

Strouse JJ, Lanzkron S, Beach MC, Haywood C, Park H, Witkop C, et al. Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children. Pediatrics. 2008 Dec. 122(6):1332-42. [Medline].

Linguraru MG, Orandi BJ, Van Uitert RL, Mukherjee N, Summers RM, Gladwin MT, et al. CT and image processing non-invasive indicators of sickle cell secondary pulmonary hypertension. Conf Proc IEEE Eng Med Biol Soc. 2008. 2008:859-62. [Medline].

Cerci SS, Suslu H, Cerci C, Yildiz M, Ozbek FM, Balci TA, et al. Different findings in Tc-99m MDP bone scintigraphy of patients with sickle cell disease: report of three cases. Ann Nucl Med. 2007 Jul. 21(5):311-4. [Medline].

Solav SV, Bhandari R, Solav P. Skeletal scintigraphy manifestations of hematologic disorders. Indian J Nucl Med. 2012 Jan. 27 (1):59-62. [Medline].

Ivan Ramirez, MD Radiologist, CMI Radiology Group

Ivan Ramirez, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Radiology, Radiological Society of North America

Disclosure: Nothing to disclose.

Welansa Asrat, MD Staff Physician, Departments of Medicine and Pediatrics, Saint Vincent’s Medical Center

Disclosure: Nothing to disclose.

Bernard D Coombs, MB, ChB, PhD Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand

Disclosure: Nothing to disclose.

William R Reinus, MD, MBA, FACR Professor of Radiology, Temple University School of Medicine; Chief of Musculoskeletal and Trauma Radiology, Vice Chair, Department of Radiology, Temple University Hospital

William R Reinus, MD, MBA, FACR is a member of the following medical societies: Alpha Omega Alpha, Sigma Xi, American College of Radiology, American Roentgen Ray Society, Radiological Society of North America

Disclosure: Nothing to disclose.

Felix S Chew, MD, MBA, MEd Professor, Department of Radiology, Vice Chairman for Academic Innovation, Section Head of Musculoskeletal Radiology, University of Washington School of Medicine

Felix S Chew, MD, MBA, MEd is a member of the following medical societies: American Roentgen Ray Society, Association of University Radiologists, Radiological Society of North America

Disclosure: Nothing to disclose.

Henrique M Lederman, MD, PhD  Professor of Radiology and Pediatric Radiology, Chief, Division of Diagnostic Imaging in Pediatrics, Federal University of Sao Paulo, Brazil

Henrique M Lederman, MD, PhD is a member of the following medical societies: Society for Pediatric Radiology

Disclosure: Nothing to disclose.

Dvorah Balsam, MD Chief, Division of Pediatric Radiology, Nassau University Medical Center; Professor, Department of Clinical Radiology, State University of New York at Stony Brook

Disclosure: Nothing to disclose.

Mark HJ Choi, MD Fellow in Musculoskeletal Radiology, Department of Radiology, University of Pennsylvania School of Medicine

Mark HJ Choi, MD is a member of the following medical societies: American College of Radiology

Disclosure: Nothing to disclose.

Sickle Cell Anemia Skeletal Imaging

Research & References of Sickle Cell Anemia Skeletal Imaging|A&C Accounting And Tax Services
Source

Share on Facebook

Tweet

Follow us